Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of potent small-molecule inhibitors to drug the undruggable steroid receptor coactivator-3
Xianzhou Song, Jianwei Chen, Mingkun Zhao, et al.
Proceedings of the National Academy of Sciences (2016) Vol. 113, Iss. 18, pp. 4970-4975
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Targeting hepatic glucose metabolism in the treatment of type 2 diabetes
Amy K. Rines, Kfir Sharabi, Clint D.J. Tavares, et al.
Nature Reviews Drug Discovery (2016) Vol. 15, Iss. 11, pp. 786-804
Open Access | Times Cited: 318
Structural underpinnings of oestrogen receptor mutations in endocrine therapy resistance
John A. Katzenellenbogen, Christopher G. Mayne, Benita S. Katzenellenbogen, et al.
Nature reviews. Cancer (2018) Vol. 18, Iss. 6, pp. 377-388
Open Access | Times Cited: 189
CBP/p300: Critical Co-Activators for Nuclear Steroid Hormone Receptors and Emerging Therapeutic Targets in Prostate and Breast Cancers
Aaron Waddell, Haojie Huang, Daiqing Liao
Cancers (2021) Vol. 13, Iss. 12, pp. 2872-2872
Open Access | Times Cited: 74
Targeting NSD2-mediated SRC-3 liquid–liquid phase separation sensitizes bortezomib treatment in multiple myeloma
Jing Liu, Ying Xie, Jing Guo, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 63
Taking advantage of the disadvantage: employing the high aqueous instability of amorphous calcium carbonate to realize burst drug release within cancer cells
Cheng Wang, Shaoqing Chen, Qin Yu, et al.
Journal of Materials Chemistry B (2017) Vol. 5, Iss. 11, pp. 2068-2073
Closed Access | Times Cited: 71
Enzalutamide therapy for advanced prostate cancer: efficacy, resistance and beyond
Simon Linder, Henk G. van der Poel, Andries M. Bergman, et al.
Endocrine Related Cancer (2018) Vol. 26, Iss. 1, pp. R31-R52
Open Access | Times Cited: 63
Pharmacological Inhibition of CBP/p300 Blocks Estrogen Receptor Alpha (ERα) Function through Suppressing Enhancer H3K27 Acetylation in Luminal Breast Cancer
Aaron Waddell, Iqbal Mahmud, Haocheng Ding, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2799-2799
Open Access | Times Cited: 47
Dynamic assembly and activation of estrogen receptor α enhancers through coregulator switching
Shino Murakami, Anusha Nagari, W. Lee Kraus
Genes & Development (2017) Vol. 31, Iss. 15, pp. 1535-1548
Open Access | Times Cited: 60
Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers
Ganesh V. Raj, Gangadhara R. Sareddy, Shihong Ma, et al.
eLife (2017) Vol. 6
Open Access | Times Cited: 53
Proteomic profiling identifies key coactivators utilized by mutant ERα proteins as potential new therapeutic targets
Leah Gates, Guowei Gu, Yue Chen, et al.
Oncogene (2018) Vol. 37, Iss. 33, pp. 4581-4598
Open Access | Times Cited: 53
Drug-induced PD-L1 expression and cell stress response in breast cancer cells can be balanced by drug combination
Yosi Gilad, Yossi Eliaz, Yang Yu, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 49
Genome-Wide Estrogen Receptor Activity in Breast Cancer
Anca M. Farcas, Sankari Nagarajan, Sabina Cosulich, et al.
Endocrinology (2020) Vol. 162, Iss. 2
Open Access | Times Cited: 45
Androgen receptor cofactors: A potential role in understanding prostate cancer
Xiang Li, Haojun Xiong, Xingzhu Mou, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116338-116338
Open Access | Times Cited: 6
Molecular Pathways: Targeting Steroid Receptor Coactivators in Cancer
David M. Lonard, Bert W. O’Malley
Clinical Cancer Research (2016) Vol. 22, Iss. 22, pp. 5403-5407
Open Access | Times Cited: 40
Targeting SRC Coactivators Blocks the Tumor-Initiating Capacity of Cancer Stem-like Cells
Aarti D. Rohira, Fei Yan, Lei Wang, et al.
Cancer Research (2017) Vol. 77, Iss. 16, pp. 4293-4304
Open Access | Times Cited: 40
Targeted Degradation of Transcription Coactivator SRC‐1 through the N‐Degron Pathway
Yeongju Lee, Jiwon Heo, Hoibin Jeong, et al.
Angewandte Chemie International Edition (2020) Vol. 59, Iss. 40, pp. 17548-17555
Closed Access | Times Cited: 35
Facile construction of irinotecan loaded mesoporous nano-formulation with surface-initiated polymerization to improve stimuli-responsive drug delivery for breast cancer therapy
Zheng Nie, Daoliang Wang, Shuangyan Wang, et al.
Heliyon (2023) Vol. 9, Iss. 4, pp. e15087-e15087
Open Access | Times Cited: 13
AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer
Amber J. Kiliti, Ghada M. Sharif, Mary Beth Martin, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 11
Steroid receptor coactivators in Treg and Th17 cell biology and function
Yosi Gilad, Ortal Shimon, Sang Jun Han, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Steroid receptor/coactivator binding inhibitors: An update
Kornelia J. Skowron, Kenneth Booker, Changfeng Cheng, et al.
Molecular and Cellular Endocrinology (2019) Vol. 493, pp. 110471-110471
Open Access | Times Cited: 35
SRC-3, a Steroid Receptor Coactivator: Implication in Cancer
Licen Li, Chu‐Xia Deng, Qiang Chen
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4760-4760
Open Access | Times Cited: 24
PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER+ breast cancer
Thu H. Truong, Elizabeth Benner, Kyla M. Hagen, et al.
Oncogene (2021) Vol. 40, Iss. 25, pp. 4384-4397
Open Access | Times Cited: 24
Ncoa2 Promotes CD8+ T cell–Mediated Antitumor Immunity by Stimulating T-cell Activation via Upregulation of PGC-1α Critical for Mitochondrial Function
Xiancai Zhong, Hongmin Wu, Ching Ouyang, et al.
Cancer Immunology Research (2023) Vol. 11, Iss. 10, pp. 1414-1431
Closed Access | Times Cited: 10
Steroid receptor coactivators present a unique opportunity for drug development in hormone-dependent cancers
Aarti D. Rohira, David M. Lonard
Biochemical Pharmacology (2017) Vol. 140, pp. 1-7
Closed Access | Times Cited: 30
Approaches towards tissue‐selective pharmacology of the mineralocorticoid receptor
Dorien Clarisse, Lisa Deng, Karolien De Bosscher, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 13, pp. 3235-3249
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top